Armata Pharmaceuticals, Inc. (ARMP) Misses Q4 EPS by 323c
Tweet
Share
E-mailGet Alerts ARMP Hot Sheet
Join SI Premium – FREE
Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q4 EPS of ($3.42), $3.23 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.48 million.
For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
